BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36017147)

  • 21. CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis.
    Han Y; Xu S; Cheng K; Diao C; Liu S; Zou W; Bi Y
    Exp Ther Med; 2021 Apr; 21(4):401. PubMed ID: 33680123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.
    Wang B; Yu J; Sun Z; Luh F; Lin D; Shen Y; Wang T; Zhang Q; Liu X
    Mol Carcinog; 2020 Aug; 59(8):908-922. PubMed ID: 32346924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma.
    Wang ZX; Ren SC; Chang ZS; Ren J
    Biomed Res Int; 2020; 2020():7102757. PubMed ID: 33204709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer.
    Daigo K; Takano A; Thang PM; Yoshitake Y; Shinohara M; Tohnai I; Murakami Y; Maegawa J; Daigo Y
    Int J Oncol; 2018 Jan; 52(1):155-165. PubMed ID: 29115586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of Brain Acid Soluble Protein 1 Inhibits Proliferation and Migration of Thyroid Cancer Cells.
    Guo RS; Yu Y; Chen J; Chen YY; Shen N; Qiu M
    Chin Med J (Engl); 2016 Jun; 129(12):1439-46. PubMed ID: 27270539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.
    Bian P; Hu W; Liu C; Li L
    Arch Biochem Biophys; 2020 Aug; 689():108461. PubMed ID: 32531316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Jin Q; Dai Y; Wang Y; Zhang S; Liu G
    J Clin Pathol; 2019 May; 72(5):354-362. PubMed ID: 30819726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
    J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of KIF11 As a Novel Target in Meningioma.
    Jungwirth G; Yu T; Moustafa M; Rapp C; Warta R; Jungk C; Sahm F; Dettling S; Zweckberger K; Lamszus K; Senft C; Loehr M; Keßler AF; Ketter R; Westphal M; Debus J; von Deimling A; Simon M; Unterberg A; Abdollahi A; Herold-Mende C
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30991738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z; Li H; Wang J; Sun C
    Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamins B2 Promotes Esophageal Cancer by Stimulating Proliferation and Inhibiting Apoptosis.
    Wang J; Ma M; Liu X
    Ann Clin Lab Sci; 2022 Mar; 52(2):202-212. PubMed ID: 35414499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
    He L; Guo S; Zhu T; Chen C; Xu K
    Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TFAP2B overexpression contributes to tumor growth and progression of thyroid cancer through the COX-2 signaling pathway.
    Fu X; Zhang H; Chen Z; Yang Z; Shi D; Liu T; Chen W; Yao F; Su X; Deng W; Chen M; Yang A
    Cell Death Dis; 2019 May; 10(6):397. PubMed ID: 31113934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma.
    Li HG; Zhao LH; Zhang ZH; Liu JZ; Ren K; Li SY; Su ZJ
    Cell Physiol Biochem; 2017; 43(5):2037-2046. PubMed ID: 29059670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulated
    Zeng J; Ma X; Wang J; Liu R; Shao Y; Hou Y; Li Z; Fang Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31101684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of P62 in the development of human thyroid cancer and its possible mechanism.
    Mao Y; Deng SJ; Su YJ; Diao C; Peng Y; Ma JF; Cheng RC
    Cancer Genet; 2021 Aug; 256-257():5-16. PubMed ID: 33780725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel mutation in
    Wang K; Zhang X; Tian T; Zhao P
    Mol Vis; 2021; 27():528-541. PubMed ID: 34526760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.
    Meng W; Wang PS; Liu J; Xue S; Wang GM; Meng XY; Chen G
    Oncol Rep; 2014 Dec; 32(6):2411-20. PubMed ID: 25231838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma.
    Li Z; Yu B; Qi F; Li F
    Front Oncol; 2021; 11():670218. PubMed ID: 33968780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.